Chemomab Therapeutics Ltd. - American Depositary Shares (CMMB) earnings
CMMB earnings moved a median of -1.06% by the close. Quarterly and annual CMMB reports and results, each read against the price at its own news timestamp. Back to the CMMB overview →
16 measured CMMB earnings events.
Where these CMMB earnings landedvs 16 measured CMMB earnings reactions
| Middle 50% of CMMB earnings reactions | -3.84% to +2.28% |
|---|---|
| Median reaction (to close) | -1.06% |
| Measured reactions | 16 |
Point-in-time · zero look-ahead
Half of the 16 CMMB earnings events with a measured close landed between -3.84% and +2.28%; 38% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Chemomab Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update | Press release | -3.57% | +6.63% | |
| Chemomab Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update | Press release | +3.15% | -0.58% | |
| Chemomab Therapeutics Announces Year End and Fourth Quarter 2025 Financial Results and Provides a Corporate Update | Press release | +0.25% | -3.50% | |
| Chemomab Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update | Press release | -2.54% | -11.64% | |
| Chemomab Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update | Press release | -2.45% | -4.86% | |
| Chemomab Therapeutics Announces First Quarter 2025 Financial Results and Provides Corporate Update | Press release | -1.60% | +8.40% | |
| Chemomab Therapeutics Announces Year End and Fourth Quarter 2024 Financial Results and Provides a Corporate Update | Press release | +2.45% | -7.36% | |
| Chemomab Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update | Press release | +2.02% | +0.58% | |
| Chemomab Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update | Press release | -0.70% | -0.70% | |
| Chemomab Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update | Press release | +0.83% | +0.83% | |
| Chemomab Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Business Update | Press release | +0.00% | -1.42% | |
| Chemomab Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update | Press release | +0.00% | +10.20% | |
| Chemomab Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update | Press release | +0.00% | -1.47% | |
| Chemomab Therapeutics Announces Year End and Fourth Quarter 2023 Financial Results and Provides a Corporate Update | Press release | +0.00% | +12.20% | |
| Chemomab Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update | Press release | +8.06% | -3.23% | |
| Chemomab Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Business Update | Press release | +0.00% | -6.33% |
Keep exploring
More CMMB: analyst actions → · SEC filings → · CMMB overview →